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Mechanisms underlying the regulated splicing of CD45 RNA have been long-standing puzzles. In this issue of
Immunity, Wu et al. (2008) identify hnRNPLL as a critical regulator of both signal-induced exon skipping in
CD45 and global alternative-transcript expression in memory T cells.CD45 is a hematopoietic receptor-like
tyrosine phosphatase that sets the
threshold for signal transduction from im-
munoreceptor tyrosine-based activation
motif (ITAM)-containing receptors, such
as the T cell receptor (TCR). Alternate
splicing of three exons (4, 5, and 6) in
CD45 produces multiple isoforms char-
acterized by differential inclusion of
segments A, B, and C, respectively (Fig-
ure 1). Furthermore, and more interest-
ingly, isoform expression is tightly regu-
lated in a cell-lineage- and stage-specific
fashion. The CD45RABC (B220) long iso-
form is almost exclusively expressed on
B cells, whereas differentiation from naive
T cells, which express various larger iso-
forms, to memory T cells is accompanied
by exon exclusion for production of the
short isoform, RO, a well-known marker
of human memory T cells (Hermiston
et al., 2003). Both exon inclusion and
exon exclusion are ‘‘active’’ processes.
Cis-regulatory sequences known as in-
tronic and exonic splicing enhancers (ISE
and ESE) recruit spliceosome machinery
via Ser-Arg rich (SR) proteins in order to
drive exon inclusion in the final processed
transcript. Conversely, intronic andexonic
splicing silencers (ISS and ESS) recruit
hnRNP proteins, which inhibit spliceo-
some recruitment and promote exon skip-
ping (Lynch, 2004).
Such tightly regulated control of isoform
expression suggests functional signifi-
cance. Alternative splicing produces tran-
script products that differ markedly in the
length of their extracellular domains and in
the extent of O-linked glycosylation sites.
Long isoforms are heavily O-glycosylated.
Expression of distinct isoforms has been
postulated to influence signaling by differ-
ential dimerization and association withthe CD4 coreceptor (Hermiston et al.,
2003). Further evidence for the functional
significance of CD45 splicing comes
from human genetics. The CD45 C77G
human polymorphism in ESS1 of exon 4
disrupts regulated splicing by failing to
silence exon 4 upon memory T cell differ-
entiation and is associated with the auto-
immune disease multiple sclerosis (Ja-
cobsen et al., 2000).
Classic studies of T cell–B cell fusion
chimeras revealed that a trans-acting
factor was required for exon exclusion in
generating small CD45 isoforms (Roth-
stein et al., 1992). The generation of the
JSL1 Jurkat cell line, in which CD45
undergoes exon exclusion upon T cell
stimulation with phorbol myristate acetate
(PMA), has been a valuable reagent for
identifying the inducible trans-acting
factor that drives inducible exon skipping
(Lynch andWeiss, 2000). Previous studies
with JSL1 cells revealed that signal-
induced splicing of CD45 required canon-
ical TCR signals, as well as new protein
synthesis (Lynch and Weiss, 2000). Intro-
duction of a CD45 minigene containing
exon 4 and flanking genomic sequence
demonstrated that cis-acting elements in
and around exon 4 were required for
inducible exon exclusion as well (Lynch
and Weiss, 2000). In subsequent work,
the minimal cis-regulatory motif required
for mediation of CD45 signal-induced
exon skipping in JSL1 cells was eluci-
dated. This activation-responsive se-
quence (ARS) motif is contained within
the larger exon 4 ESS1 (Rothrock et al.,
2003). Although previous studies of the
CD45 exon 4 ESS1 identified the spliceo-
somal repressor hnRNPL as an associ-
ated factor that promotes basal exon
exclusion in T cells, this did not accountImmunity 29,for signal-induced exon skipping (Roth-
rock et al., 2005).
These observations and tools paved
the way for three recently published
studies, including Wu et al. (2008) in the
current issue of Immunity, that have un-
masked hnRNPLL as the signal-induced
trans-acting factor that directs CD45
exon skipping (Oberdoerffer et al., 2008;
Topp et al., 2008) (Wu et al., 2008). The
three studies took different approaches
to converge upon the same answer.
Oberdoerffer et al. and Topp et al. took
advantage of the JSL1 cell line to screen
for factors that are required for exon skip-
ping after PMA treatment. Oberdoerffer
et al. identified hnRNPLL by using an
shRNA lentiviral library, whereas Topp
et al. identified the same gene using
a dual-reporter assay and an mRNA
microarray. Both groups showed, via
overexpression and knockdown, that
hnRNPLL is necessary and sufficient in
the context of JSL1 cells, as well as
primary T cells, for mediation of signal-
induced exon skipping of CD45. Topp
et al. further mapped the interaction of
hnRNPLL and the CD45 exon 4 transcript
and confirmed binding to the previously
identified cis-regulatory ARS.
In this issue, Wu et al. report the identifi-
cation of hnRNPLL as a CD45 splicing
regulator in mice. An ENU mutagenesis
screen identified a mouse mutant,
Thunder, characterized by abnormal
splicing of CD45, as well as by T cell
lymphopenia. These mice exhibit a cell-
intrinsic failure to skip CD45 exons upon
T cell differentiation, such that high-
molecular-weight isoforms of CD45 are
not effectively silenced in memory
T cells. Mapping studies identified a single
amino acid substitution, V136D, in theDecember 19, 2008 ª2008 Elsevier Inc. 839
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PreviewsFigure 1. Alternative Splicing of CD45
Alternative splicing of exons 4, 5, and 6 in naive T cells permits the inclusion of heavily glycosylated segments A, B, and C, respectively, in CD45
cell-surface protein. Variable amounts of high molecular weight isoforms, including RABC, RAB, RBC, and RB are detected on the surface of naive T cells.
Upon differentiation to memory T cells, upregulation of hnRNPLL inhibits splicing and inclusion of exons 4, 5, and 6, generating predominantly the short isoform
CD45RO.RNA-recognition motif of hnRNPLL.
Structural and biophysical studies
suggest that the mutation does not
directly affect the RNA-binding surface of
the protein but, rather, destabilizes its
structure, leading to a hypomorphic allele.
As predicted by classic studies of the
inducible trans-acting factor, expression
of hnRNPLL is itself upregulated upon
T cell differentiation, in marked contrast
to theconstitutively expressedandclosely
related hnRNPL.
Wu et al. describe the first whole-
organism phenotype for an hnRNPLL
hypomorph and identify a profound cell-
intrinsic survival defect in T cells. They
show nicely that this is related neither to
a defect in TCR- or lymphopenia-induced
proliferation nor, specifically, to perturbed
T cell differentiation and cytokine produc-
tion. It will be interesting to identify the
precise molecular mechanism for this
defect, especially because it promises to
shed further light upon the functional
significance of regulated RNA splicing in
T cells.
Both Oberdoerffer et al. and Wu et al.
took a step beyond elucidating the regula-
tion of CD45 splicing by using exon-array
analysis to identify other alternatively
spliced targets of hnRNPLL that are
coordinately regulated upon T cell differ-
entiation. This identified hundreds of
hits, suggesting that an entire program
of coordinate gene regulation could be840 Immunity 29, December 19, 2008 ª200imposed by alternative splicing in
response to specific stimuli. Because
hnRNPLL might be a ‘‘master regulator
of’’ (or essential for) a global program of
alternative splicing, isolating the func-
tional consequences of CD45 alternative
splicing with the use of the Thunder mice
will be quite challenging. In order to
identify the in vivo functional significance
of CD45 splicing for immune system
development and function, isolation of
a CD45-specific splicing defect will be
necessary, perhaps by generation of the
C77G human polymorphism or mutation
of other sequences in the ARS of exons
4, 5, or 6.
It remains to be established, perhaps
with the use of the Thunder mice, what
other broad functions of memory T cells
are regulated by alternative splicing. It
will be interesting, indeed, to study
Thunder T cell memory in the context of
infection and immunization in order to
identify a role for the hnRNPLL-regulated
splicing program. Perhaps T cell survival
alone is perturbed, but it is likely that other
characteristics of memory fate, such as
signaling, antigen-sensitivity, and even
effector functions, could be affected.
Furthermore, the array data offer an
opportunity to identify new markers of
memory cell fate analogous to CD45RO.
Another layer of complexity is offered
when we consider that other regulators
of splicing are induced or suppressed8 Elsevier Inc.upon memory T cell differentiation. For
instance, SR proteins are highly upregu-
lated during differentiation to the memory
T cell fate (ten Dam et al., 2000). In this
fashion, combinatorial, rather than simply
binary, control of alternative splicing
programs can be achieved.
Seventy-five percent of proteins en-
coded by the human genome are thought
to undergo alternative splicing (Lynch,
2004). In this regard, highly regulated,
coordinately enforced splicing is reminis-
cent of other global layers of regulated
gene expression. Not only is this nonca-
nonical regulatory system reminiscent of
conventional enhancers, repressors, and
transcription factors, but also of micro-
RNAs and chromatin remodeling. Decod-
ing the contexts and functional impli-
cations of such broad programs will be
the work of many years to come. The
immune system promises to be a fruitful
system in which to understand this exten-
sion of the ‘‘genetic code.’’
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The transcription factor IRF-4 is nec
(2008) show that IRF-4-binding prote
of the cytokines IL-21 and IL-17.
The discovery of T helper 17 (Th17) cells
has markedly advanced our under-
standing on many inflammatory and auto-
immune diseases (Dong, 2008). Elevated
amounts of interleukin-17 (IL-17) and
IL-21 are found in rheumatoid arthritis
(RA), systemic lupus erythematosus, and
psoriasis patients. In addition, blocking
of IL-17 or IL-21 in a mouse model of RA
decreases joint damage and destruction
of cartilages and bones. Given the patho-
genic function of Th17 cell cytokines in
autoimmune disease such as RA, it is
critical to understand the control of Th17
cell differentiation. However, the molec-
ular mechanisms involved in the negative
regulation of Th17 cell differentiation have
not been fully defined. In this issue of
Immunity, Chen et al. describe IRF-
4-binding protein (IBP) as a key factor in
controlling T cell-mediated autoimmunity
(Chen et al., 2008).
Th17 cells produce IL-17, IL-17F, and
IL-22, which together regulate inflamma-
tory responses by tissue cells (Dong,
2008). Th17 cell differentiation in mouse
is initiated by the cytokines TGF-b and
IL-6. In addition, Th17 cells also highly
express IL-21, an autocrine cytokine that
synergizes with TGF-b to induce Th17
cell differentiation (Dong, 2008). STAT3,Rothrock, C.R., House, A.E., and Lynch, K.W.
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in is a critical negative regulator of IR
a transcription factor downstream of IL-6
signaling, is essential for Th17 cell differ-
entiation, possibly via the induction of
two nuclear receptors, RORa and RORgt.
Interestingly, IL-21 expression requires
STAT3 but not RORg (Nurieva et al.,
2007). Another molecule, interferon regu-
latory factor 4 (IRF-4), is also critical for
the generation of Th17 cells, and conse-
quently for the development of experi-
mental autoimmune encephalomyelitis
(EAE), amousemodel ofmultiple sclerosis
(Brustle et al., 2007). IRF-4-deficient Th
cells fail to differentiate into Th17 cells. In
addition, Irf4/ Th cells exhibit impaired
expression of RORgt (Brustle et al., 2007).
Gupta et al. (2003) identified IRF-
4-binding protein (IBP), which exhibits
marked homology with the protein
SWAP-70. In contrast to SWAP-70, IBP
is highly expressed in T cells and, upon
T cell receptor (TCR) engagement, is
rapidly phosphorylated by the kinase
Lck and recruited to the immunological
synapse (Gupta et al., 2003). The same
group reported that IBP-deficient mice
on C57BL/6 and 129 mixed background
spontaneously developed a lupus-like
syndrome, including the accumulation of
effector and memory T cells and IgG+ B
cells, profound hypergammaglobuline-
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this issue of Immunity, Chen et al.
F-4 function, regulating production
mia, and autoantibody production (Fanzo
et al., 2006). Thus, it was proposed that
IBP is required for optimal T cell effector
function, lymphocyte homeostasis, and
the prevention of systemic autoimmunity.
To further determine the preventive role
of IBP in the development of autoimmu-
nity, Chen et al. (2008) backcrossed IBP-
deficient mice on Balb/c background
and then crossed to DO11.10 TCR trans-
genic mice. Chen et al. (2008) observed
that at 7 weeks of age, thesemice sponta-
neously developed arthritis characterized
by joint erythema and swelling and
increased titers of autoantibodies such
as rheumatoid factor, collagen II anti-
bodies, and cyclin citrullinated peptide
(CCP) antibodies. Beginning at 3 months
of age, these mice started to die, as
a result of the development of large-
vessel vasculitis. In exploring the mecha-
nisms underlying these fatal disorders
associated with IBP deficiency, Chen
et al. (2008) first examined the possibility
of defective central tolerance. However,
using two models of central tolerance,
they found that spontaneous develop-
ment of arthritis and vasculaties in IBP-
deficient DO11.10 mice was not due to
failure of elimination of autoreactive
T cells in the thymusbynegative selection.
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